Literature DB >> 28825860

Attitudes, Beliefs, and Barriers to PrEP Among Trans Men.

Stefan Rowniak1, Chenit Ong-Flaherty1, Nancy Selix1, Niko Kowell2.   

Abstract

The study examined the attitudes and knowledge of transgender men (trans men) regarding pre-exposure prophylaxis (PrEP) for HIV. Three focus groups of trans men were conducted with a trans male facilitator for a total of 21 participants. Six themes were identified; the range of information about PrEP and possible side effects, the economic realities for trans men, finding a trans-competent provider, trans male sexuality, the importance of contraception, and condom use. Despite identified risk and some information that has been disseminated, many trans men still lack adequate information regarding PrEP. There exist significant barriers to PrEP access for trans men. Participants commented that many providers avoid important discussions regarding sexuality and contraception. The education of health care professionals must include competency in working with transgender populations. More research is needed with regard to interactions between PrEP, testosterone, and hormonal contraception.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28825860     DOI: 10.1521/aeap.2017.29.4.302

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  16 in total

1.  High Rates of PrEP Eligibility but Low Rates of PrEP Access Among a National Sample of Transmasculine Individuals.

Authors:  Sarit A Golub; Rachel A Fikslin; Lila Starbuck; Augustus Klein
Journal:  J Acquir Immune Defic Syndr       Date:  2019-09-01       Impact factor: 3.731

2.  Accessing Pre-exposure Prophylaxis (PrEP): Perceptions of Current and Potential PrEP Users in Birmingham, Alabama.

Authors:  Whitney S Rice; Kristi L Stringer; Maira Sohail; Kaylee B Crockett; Ghislaine C Atkins; Kachina Kudroff; D Scott Batey; Joshua Hicks; Janet M Turan; Michael J Mugavero; Bulent Turan
Journal:  AIDS Behav       Date:  2019-11

3.  Putting the Dissemination and Implementation in Infectious Diseases.

Authors:  Jason P Burnham; Elvin Geng; Chinmayi Venkatram; Graham A Colditz; Virginia R McKay
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

4.  Geographic Variation in HIV Testing Among Transgender and Nonbinary Adults in the United States.

Authors:  Diana M Tordoff; Sahar Zangeneh; Christine M Khosropour; Sara N Glick; Raymond Scott McClelland; Dobromir Dimitrov; Sari Reisner; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-15       Impact factor: 3.771

Review 5.  Optimizing HIV prevention and care for transgender adults.

Authors:  Jordan E Lake; Jesse L Clark
Journal:  AIDS       Date:  2019-03-01       Impact factor: 4.177

Review 6.  Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know.

Authors:  Kenneth A Katz; Andrew J Park; Julia L Marcus
Journal:  Dermatol Clin       Date:  2019-11-23       Impact factor: 3.478

Review 7.  A Review of Recent HIV Prevention Interventions and Future Considerations for Nursing Science.

Authors:  Megan Threats; Bridgette M Brawner; Tiffany M Montgomery; Jasmine Abrams; Loretta Sweet Jemmott; Pierre-Cedric Crouch; Kellie Freeborn; Emiko Kamitani; Comfort Enah
Journal:  J Assoc Nurses AIDS Care       Date:  2021 May-Jun 01       Impact factor: 1.809

8.  Oral Pre-Exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults.

Authors:  Tanya L Kowalczyk Mullins; Corinne E Lehmann
Journal:  Curr Pediatr Rep       Date:  2018-04-12

9.  HIV Pre-Exposure Prophylaxis (PrEP) Counseling in Germany: Knowledge, Attitudes and Practice in Non-governmental and in Public HIV and STI Testing and Counseling Centers.

Authors:  Frank Kutscha; Matthew Gaskins; Mary Sammons; Alexander Nast; Ricardo Niklas Werner
Journal:  Front Public Health       Date:  2020-07-14

Review 10.  Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.

Authors:  Kenneth H Mayer; Allison Agwu; David Malebranche
Journal:  Adv Ther       Date:  2020-03-30       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.